Sodium-Glucose Co-Transporter 2 Inhibition With Empagliflozin Improves Cardiac Function After Cardiac Arrest in Rats by Enhancing Mitochondrial Energy Metabolism
Empagliflozin is a newly developed antidiabetic drug to reduce hyperglycaemia by highly selective inhibition of sodium-glucose co-transporter 2. Hyperglycaemia is commonly seen in patients after cardiac arrest (CA) and is associated with worse outcomes. In this study, we examined the effects of empa...
Saved in:
Main Authors: | Yunke Tan (Author), Kai Yu (Author), Lian Liang (Author), Yuanshan Liu (Author), Fengqing Song (Author), Qiulin Ge (Author), Xiangshao Fang (Author), Tao Yu (Author), Zitong Huang (Author), Longyuan Jiang (Author), Peng Wang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
LDK378 improves micro- and macro-circulation via alleviating STING-mediated inflammatory injury in a Sepsis rat model induced by Cecal ligation and puncture
by: Weiwei Ge, et al.
Published: (2019) -
Lactate as a Potential Biomarker of Sepsis in a Rat Cecal Ligation and Puncture Model
by: Xiaozhu Zhai, et al.
Published: (2018) -
Non-Viral Gene Delivery Systems for Treatment of Myocardial Infarction: Targeting Strategies and Cardiac Cell Modulation
by: Jieting Wang, et al.
Published: (2021) -
Empagliflozin improves chronic hypercortisolism-induced abnormal myocardial structure and cardiac function in mice
by: Qing-Qing Zhang, et al.
Published: (2020) -
Social integration, physical and mental health and subjective well-being in the floating population-a moderated mediation analysis
by: Chengcheng Fei, et al.
Published: (2023)